Currently, there are several treatment options for the disease.
(1) Acute treatment: High-dose hormone shocks and plasma replacement are available. Hormone shock treatment is inexpensive and has the advantage of fast onset of action, making it a classic treatment option. However, with repeated use of large amounts, side effects such as osteoporosis, femoral head necrosis, obesity and infection may occur; plasma replacement is relatively more expensive but has fewer adverse effects and is certainly effective. In severe cases, hormone shock can be combined with plasma exchange. In addition, intravenous gammaglobulin infusion has some effectiveness, but more evidence is needed to support this.
(2) Treatment in remission: Immunosuppression is recommended to prevent relapse. There are various types of immunosuppressants. Traditional immunosuppressants, such as azathioprine and methotrexate, are less expensive but may have greater side effects and azathioprine is slow to take effect, taking 3-6 months; newer immunosuppressants, such as morte-macrolide, and biologics, such as rituximab, are relatively expensive and need to be chosen according to the risk of relapse and in the light of financial circumstances.